Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Enfusion, Inc. Class A Common Stock (NY: ENFN )

10.92 +0.11 (+1.02%)
Official Closing Price Updated: 7:00 PM EST, Jan 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

All News about Enfusion, Inc. Class A Common Stock

< Previous 1 2 3 4 5 Next >
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN and EDBL on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN, ITCI, EDBL on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
ENFUSION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enfusion, Inc. - ENFN
From Kahn Swick & Foti, LLC
Via Business Wire
ENFN Investors Have the Opportunity to Join Investigation of Enfusion, Inc. With the Schall Law Firm
From The Schall Law Firm
Via Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Enfusion, Inc. (NYSE - ENFN), Intra-Cellular Therapies, Inc. (Nasdaq - ITCI), Paycor HCM, Inc. (Nasdaq - PYCR), Accolade, Inc. (Nasdaq - ACCD)
From Brodsky & Smith LLC
Via GlobeNewswire
ENFN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Enfusion, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Shareholder Alert: Ademi LLP Investigates Whether Enfusion, Inc. Is Obtaining a Fair Price for Its Public Shareholders
From Ademi LLP
Via Business Wire
Clearwater Analytics to Acquire Enfusion for $1.5 Billion Expanding its Investment Management Platform with Front-to-Back Capabilities
From Clearwater Analytics
Via Business Wire
This Analyst With 85% Accuracy Rate Sees Around 10% Upside In Alphabet - Here Are 5 Stock Picks For 2024 From Wall Street's Most Accurate Analysts
Via Benzinga
This Analyst With 82% Accuracy Rate Sees Around 28% Upside In Apple - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts
Via Benzinga
12 Information Technology Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Fastly Stock Gets IBD Rating Upgrade
One key metric to look for in a stock is an 80-plus Relative Strength Rating. Fastly stock cleared that benchmark Tuesday, with a jump to 84. 
Via Investor's Business Daily
Enfusion To Present at Upcoming Investor Events
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Third Quarter 2024 Results
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Key Leadership Team Additions to Drive Client Success and Fuel Innovation
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Date of Third Quarter 2024 Results
From Enfusion, Inc.
Via Business Wire
ENFN Investors Have Opportunity to Join Enfusion, Inc. Securities Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Enfusion, Inc. (ENFN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Enfusion, Inc. (ENFN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
ENFN Investors Have Opportunity to Join Enfusion, Inc. Securities Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
ENFN Stock Earnings: Enfusion Misses EPS, Misses Revenue for Q2 2024
ENFN stock results show that Enfusion missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Enfusion Announces Second Quarter 2024 Results
From Enfusion, Inc.
Via Business Wire
Enfusion Introduces the Next Phase of Portfolio Workbench, Empowering Asset Managers with Increased Efficiency and Flexibility
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Date of Second Quarter 2024 Results
From Enfusion, Inc.
Via Business Wire
Enfusion To Present at Upcoming Investor Events
From Enfusion, Inc.
Via Business Wire
ENFN Stock Earnings: Enfusion Beats EPS, Beats Revenue for Q1 2024
ENFN stock results show that Enfusion beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Enfusion Announces First Quarter 2024 Results
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Date of First Quarter 2024 Results
From Enfusion, Inc.
Via Business Wire
The 3 Most Undervalued Under-$10 Stocks to Buy in April 2024
Equities have only become more expensive, but investors should still lookout for the most undervalued under-$10 stocks to buy in April. 
Via InvestorPlace
Kayne Anderson Strengthens Investment Operations After Successful Platform Migration to Enfusion
From Enfusion
Via Business Wire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.